Department of Neurosurgery, Renmin Hospital of Wuhan University, Wuhan, China.
Central Laboratory, Renmin Hospital of Wuhan University, Wuhan, China.
CNS Neurosci Ther. 2024 Jul;30(7):e14816. doi: 10.1111/cns.14816.
This study aimed to explore the mechanisms of transient receptor potential (TRP) channels on the immune microenvironment and develop a TRP-related signature for predicting prognosis, immunotherapy response, and drug sensitivity in gliomas.
Based on the unsupervised clustering algorithm, we identified novel TRP channel clusters and investigated their biological function, immune microenvironment, and genomic heterogeneity. In vitro and in vivo experiments revealed the association between TRPV2 and macrophages. Subsequently, based on 96 machine learning algorithms and six independent glioma cohorts, we constructed a machine learning-based TRP channel signature (MLTS). The performance of the MLTS in predicting prognosis, immunotherapy response, and drug sensitivity was evaluated.
Patients with high expression levels of TRP channel genes had worse prognoses, higher tumor mutation burden, and more activated immunosuppressive microenvironment. Meanwhile, TRPV2 was identified as the most essential regulator in TRP channels. TRPV2 activation could promote macrophages migration toward malignant cells and alleviate glioma prognosis. Furthermore, MLTS could work independently of common clinical features and present stable and superior prediction performance.
This study investigated the comprehensive effect of TRP channel genes in gliomas and provided a promising tool for designing effective, precise treatment strategies.
本研究旨在探讨瞬时受体电位(TRP)通道在免疫微环境中的作用机制,并建立一个与 TRP 相关的标志物,用于预测胶质瘤的预后、免疫治疗反应和药物敏感性。
我们基于无监督聚类算法,确定了新的 TRP 通道簇,并研究了它们的生物学功能、免疫微环境和基因组异质性。体外和体内实验揭示了 TRPV2 与巨噬细胞之间的关联。随后,我们基于 96 种机器学习算法和 6 个独立的胶质瘤队列,构建了基于机器学习的 TRP 通道标志物(MLTS)。评估了 MLTS 在预测预后、免疫治疗反应和药物敏感性方面的性能。
高表达 TRP 通道基因的患者预后较差,肿瘤突变负担较高,免疫抑制微环境更为活跃。同时,TRPV2 被鉴定为 TRP 通道中最关键的调节因子。TRPV2 的激活可以促进巨噬细胞向恶性细胞迁移,并改善胶质瘤的预后。此外,MLTS 可以独立于常见的临床特征,具有稳定和优越的预测性能。
本研究全面探讨了 TRP 通道基因在胶质瘤中的综合作用,并为设计有效、精确的治疗策略提供了有前途的工具。